OH2 injection approved by CDE for inclusion in breakthrough treatment varieties
On February 25, 2023, Wuhan Binhui Biotechnology Co., Ltd.'s first candidate drug for oncolytic virus, recomb...
2023-10-11
2023-10-11
2023-10-11
2023-10-11
2023-10-11
2023-10-11
Total {{total}}
Mr. Xu 19025438700
Business Cooperation：
Dr. Xu 19025438700 WeChat：xiaoboo365
Virus Vector：
Manager Shi 15391503730 WeChat：shixiaotai611
Nucleic Acid Products：
Manager Ni 13437112357 WeChat：go-ahead-no-back
Protein Products：
Manager Zhou 18771147489 WeChat：huhu_ai_junjun
Genetic Products：
Manager Wang 13067989761 WeChat：wry12121
Instrument and Equipment：
Manager Ni 13437112357 WeChat：go-ahead-no-back
Test Kit：
Manager Liu 15207178732 WeChat：Q15207178732
xuxiaobo@binhui-bio.com
0
Address：No. 778 Chuangxin West Road, China (Shanghai) Pilot Free Trade Zone
Business Call：Mr. Xu 19025438700
Enterprise Mailbox：xuxiaobo@binhui-bio.com
Url Domain：rainminda.com
